Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
28
RPRX Quote, Financials, Valuation and Earnings
Last price:
$31.94
Seasonality move
:
-5.07%
Day range:
$30.96 - $32.01
52-week range:
$24.05 - $34.20
Dividend yield:
2.66%
P/E ratio:
17.72x
P/S ratio:
8.39x
P/B ratio:
1.99x
Volume:
5.9M
Avg. volume:
4.9M
1-year change:
9.98%
Market cap:
$13.8B
Revenue:
$2.3B
EPS (TTM):
$1.80
RPRX Analysts' Consensus Rating
The 6 analysts providing 12-month price projections for Royalty Pharma PLC shares anticipate an average target of $40.04, ranging from a low estimate of $30.14 to a high estimate of $47.00. This average target implies a growth of 25.31% compared to the current stock price of $31.95.
Consensus Price Target
$40.04
Highest Price Target
$47.00
Lowest Price Target
$30.14
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
RPRX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
